Sepsis-induced alteration in T-cell Ca(2+) signaling in neonatal rats.
D000818:Animals; D000831:Animals, Newborn / Q000276:immunology*; D001442:Bacteroides Infections / Q000276:immunology; D002118:Calcium / Q000378:metabolism*; D003208:Concanavalin A / Q000494:pharmacology; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015232:Dinoprostone / Q000502:physiology; D004927:Escherichia coli Infections / Q000276:immunology; D007527:Isoenzymes / Q000037:antagonists & inhibitors; D008213:Lymphocyte Activation; D008565:Membrane Proteins; D009578:Nitrobenzenes / Q000494:pharmacology; D011451:Prostaglandin-Endoperoxide Synthases; D051381:Rats; D017207:Rats, Sprague-Dawley; D000077185:Resveratrol; D018805:Sepsis / Q000276:immunology*; D015398:Signal Transduction; D013154:Spleen / Q000276:immunology / Q000378:metabolism; D013267:Stilbenes / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D013601:T-Lymphocytes / Q000276:immunology*